Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the trial is to provide continued access to TMC278 for subjects who were randomized and treated with TMC278 in the Phase IIb (C204) or Phase III trials (C209 and C215), and who, at the time of roll-over, experience and are expected to continue experiencing clinical benefit from TMC278 treatment.
Critère d'inclusion
- HIV-1 infection